Stabilization without Rituximab after Disease Activation in an Alemtuzumab-Treated Patient with MS and a Literature Overview

October 16, 2019 from 8:00 pm to 9:00 pm

Join us for the live journal club on Wednesday, October 16, 2019 at 8 pm (ET).

Series Title: Advanced Perspectives in MS: A Virtual Journal Club Series for the Advanced Practice Multiple Sclerosis Clinician

Article Title: Stabilization without Rituximab after Disease Activation in an Alemtuzumab-Treated Patient with Multiple Sclerosis and a Literature Overview

To participate in the discussion, please email Jennifer Pichardo at jpichardo@mscare.org.

To register for the live webinar, please click here.

Description

Due to the complex challenges presented by multiple sclerosis, the ever-changing landscape of treatment options, and the evolving nature of care trends for patients, it is vitally important that clinicians treating MS patients have access to the latest information available regarding the disease. Journal articles are a perfect example of the timely education that is required to keep pace with the current clinical environment. These articles are normally fairly brief, which allows busy practitioners to fit education into their schedule in manageable blocks of time. Additionally, research which is newly published in journals, typically contains the most up-to-date information available, eliminating the need to check for accuracy.

These live and enduring webinars will offer continuing education credits for physicians, PAs, nursing professionals, and pharmacists (if applicable) and will occur every other month for five sessions. Following the live broadcast, the event will be archived for one year.

Target Audience

This activity has been designed to meet the educational needs of physicians, PAs, nursing professionals, pharmacists, and other members of the healthcare team involved in the management of patients with MS.

Learning Objectives

Upon completing this activity, participants should be better able to:

Identify the latest research and clinical information available in the literature with regard to MS diagnosis, treatment, and monitoring

Faculty

Bryan D. Walker, MHS, PA-C, MSCS, Moderator Duke University Medical Center Durham, NC

Chantal Kahovec, NP, Author Saskatoon Multiple Sclerosis Clinic Saskatoon, SK Canada

Michael C. Levin, MD, FRCPC, FAAN, FANA, Author Saskatoon Multiple Sclerosis Clinic Saskatoon, SK Canada

Commercial Support Acknowledgment

This activity is supported by educational grants from Celgene Corporation, EMD Serono, Genentech, and Mallinckrodt Pharmaceuticals.

Accreditation Statement and Credit Designation

In support of improving patient care, the Consortium of Multiple Sclerosis Centers (CMSC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The CMSC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.

Physicians

The Consortium of Multiple Sclerosis Centers designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs

The Consortium of Multiple Sclerosis Centers designates this live activity for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurses

The Consortium of Multiple Sclerosis Centers designates this live activity for 1.0 contact hours of continuing education (1.0 in the area of pharmacology) for nurses.

Pharmacists

The Consortium of Multiple Sclerosis Centers (CMSC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education and will award 1 contact hours (.1 CEUs) to pharmacists who (1) complete the activity and (2) complete the evaluation form. The Universal Activity Number (UAN) for this activity is JA4008165-0000-19-005-L01-P. This is a knowledge-based activity.

Upon successful completion of the activity, your CE credits will be submitted electronically to the NABP CPE Monitor service. Important: Pharmacists must complete the evaluation no later than November 27, 2019. For information about CPE Monitor, visit https://nabp.pharmacy/cpe-monitor-service/

Certificate of Participation for Other Healthcare Professionals

A Certificate of Participation will be given upon completion of course requirements enabling participants to register their credit with the appropriate licensing boards or associations. Participants may apply for other accreditations using procedures established by specific organizations.